IPO Price History
Closed
Nidan Laboratories and Healthcare Limited logo

Nidan Laboratories and Healthcare Limited IPO

SME IPOListedNIDANNSE
Current Market Price (CMP)
₹33(-73.60%)
Current Price (CMP)
₹33(-73.60%)

Live Market Quote

Listing Price & Gain
₹123.90(-0.88%)

Day 1 Exchange Open

IPO Issue Price
₹125

Band: ₹125

Total Subscription
1.71x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
28 Oct 2021
IPO Bidding Closes
02 Nov 2021
Allotment & Refunds
Completed
Exchange Listing Day
12 Nov 2021

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 1.71x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)0x
Non-Institutional Investors (NII / HNI)0x
Retail Individual Investors (RII)0x
Total Subscription1.71x
Updated as on 02-Nov-2021 17:00:00

Listing Day & Return Performance

Listing Day Gain-0.88%
₹125 (Issue) → ₹123.90 (List)
Per share profit: ₹-1.10
Holding Return (Till Date)-73.60%
₹125 (Issue) → ₹33 (CMP)
Net gain per share: ₹-92.00
Post-Listing Performance (Listing Day → Today):-73.37%

About Nidan Laboratories and Healthcare Limited IPO

Nidan Laboratories and Healthcare Limited is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 28 Oct 2021 and concluded on 02 Nov 2021, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹125.

During the bidding window, Nidan Laboratories and Healthcare Limited recorded an overall subscription of 1.71 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Nidan Laboratories and Healthcare Limited officially debuted on the stock exchanges on 12 Nov 2021 at an opening listing price of ₹123.90, delivering a listing day return of -0.88% (discount) over the final issue price. As per the latest market data, the stock trades at ₹33, representing an overall decline of -73.60% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Nidan Laboratories and Healthcare Limited IPO?
The issue price of Nidan Laboratories and Healthcare Limited IPO was fixed at ₹125 per equity share. The indicative bidding price band was ₹125.
What were the open, close, and listing dates for Nidan Laboratories and Healthcare Limited IPO?
Nidan Laboratories and Healthcare Limited IPO opened on 28 Oct 2021, closed on 02 Nov 2021, listed on 12 Nov 2021.
How much was Nidan Laboratories and Healthcare Limited IPO subscribed?
The IPO received an overall subscription of 1.71 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Nidan Laboratories and Healthcare Limited IPO?
Nidan Laboratories and Healthcare Limited IPO listed on the stock exchange at ₹123.90, delivering a listing discount of 0.88% compared to the IPO issue price of ₹125.
Is Nidan Laboratories and Healthcare Limited IPO a Mainboard or SME IPO?
Nidan Laboratories and Healthcare Limited IPO is a SME IPO listed on the SME platform of NSE.
What is the current return of Nidan Laboratories and Healthcare Limited IPO since its IPO?
At the latest market quote of ₹33, Nidan Laboratories and Healthcare Limited IPO has generated an all-time return of -73.60% since its initial public offering.

Related SME IPOs (2021)

VIVO
Vivo Collaboration Solutions Limited
₹82+333.05%
UNITEDPOLY
United Polyfab Gujarat Limited
₹17-89.76%
HECPROJECT
HEC Infra Projects Limited
₹38-3.03%
FOCE
Foce India Limited
₹225-58.33%